| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate |
2005-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2008-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2008500845-A |
| titleOfInvention |
Bioresorbable stent having a reservoir of beneficial agent |
| abstract |
A bioresorbable drug delivery stent includes a generally cylindrical expandable stent formed from a bioresorbable material and a beneficial agent matrix including a bioresorbable polymer and a drug formed within the stent. A plurality of reservoirs or openings. The bioresorbable stent material may be a bioresorbable alloy, a bioresorbable polymer, or other bioresorbable material having sufficient structural integrity to support a lumen such as a vascular lumen for a period of time. be able to. A reservoir containing a beneficial agent matrix can deliver a beneficial agent, such as an anti-restenosis drug, during the administration period, which generally retains the bioresorbable stent within the lumen. Within hours. The beneficial agent matrix may comprise one or more bioresorbable polymers in combination with one or more therapeutic agents or drugs, wherein the beneficial agent matrix structure is as desired for the drug. It can be programmed to achieve a release profile and the desired duration of administration. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010172705-A |
| priorityDate |
2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |